Evaluating a multidimensional support program to support breast cancer survivors' transition back to suitable work

Not Applicable

• Conditions: Breast Cancer survivors; Cancer - Breast; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation

• Registration Number: ACTRN12618001985279
• Lead Sponsor: Dianne Sheppard

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-11
• Last Update Posted: 7 January 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Breast cancer survivors unable to work in their regular (pre-diagnosis) capacity for at least 3 months due to breast cancer. Potential participants should not yet have returned to work at full capacity and need to have been working prior to diagnosis and treatment for their breast cancer.

Exclusion Criteria

Those to be excluded include those:
- NOT requiring support to facilitate a transition back to work (self-report)
- whose breast cancer is a recurrence (as opposed to first incidence)
- whose treatment was completed longer than 6 months ago
- whose health and other circumstances indicate a lack of readiness to participate in the intervention

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Return to work (RTW) status: Categorically defined as ‘Improved work status (hours/duties)’ relative to referral; Same work status (hours/duties) relative to referral; Reduced work status (hours/duties) relative to referral. Self report.[Baseline, 6 months post-intervention];Perceived support at work (Cancer empowerment questionnaire score)[Baseline, 6 months post-intervention];Work capacity: Categorically defined as ‘Improved work capacity’ relative to referral; Same work capacity relative to referral; Reduced work capacity relative to referral. Determined by a standardised set of questions delivered by the OR consultant.[Baseline, 6 months]